TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15683137

Group type: EXPERIMENTAL
Intervention: Declarative memory task
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nonlearning control task
Number of subjects: 24
Study: 11641687

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 738

Group type: COMPARATOR
Intervention: Intravenous analgesia
Number of subjects: 738
Study: 9766292

Group type: EXPERIMENTAL
Intervention: Exercise intervention for fatigue management
Number of subjects: 50
Study: 8053585

Group type: EXPERIMENTAL
Intervention: Propofol at target blood concentration 2 micrograms/ml
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propofol at target blood concentration 4 micrograms/ml
Number of subjects: 6

Group type: COMPARATOR
Intervention: Epidural anesthesia alone (control)
Number of subjects: 6
Study: 2903191

Group type: EXPERIMENTAL
Intervention: Intensified antihypertensive treatment aiming to lower diastolic blood pressure to less than or equal to 80 mmHg.
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Unchanged antihypertensive treatment.
Number of subjects: 2000
Study: 31005904

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) + standard care
Number of subjects: 270

Group type: COMPARATOR
Intervention: Sham electroacupuncture + standard care
Number of subjects: 270

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 270
Study: 28483560

Group type: EXPERIMENTAL
Intervention: 12% carbohydrate-electrolyte beverage (CHO; 60g×500ml-1, Na+ 205mg×500ml-1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 12% carbohydrate-electrolyte beverage (CHO)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water (Wat)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo-electrolyte (PL)
Number of subjects: 15
Study: 26377418

Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC) prevention system
Number of subjects: 3986
Study: 22890369

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone (IVTA) 4 mg/0.1 mL
Number of subjects: 27
Study: 20731637

Group type: EXPERIMENTAL
Intervention: Nicotine (2 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 19809604

Group type: EXPERIMENTAL
Intervention: Extended-duration VTE prophylaxis for 28 to 35 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacologic thromboprophylaxis with low‐molecular‐weight heparins, vitamin K antagonists, or fondaparinux
Number of subjects: 0
Study: 16996338

Group type: EXPERIMENTAL
Intervention: L-EUS
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: TA-EUS
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: FNA (performed in 16 of the 27 subjects)
Number of subjects: 43
Study: 14584962

Group type: EXPERIMENTAL
Intervention: Deramciclane 30 mg intravenous administration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Deramciclane oral administration (solution)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Deramciclane oral administration (tablet)
Number of subjects: 12
Study: 15105065

Group type: EXPERIMENTAL
Intervention: Antepartum, multicomponent intervention (counseling, videotape about OCs, written material)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care (resident-physician counseling)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Antepartum, multicomponent intervention
Number of subjects: 43
Study: 10405887

Group type: EXPERIMENTAL
Intervention: RT‐PCR detection of rotaviruses
Number of subjects: 2398

Group type: COMPARATOR
Intervention: G2 rotaviruses
Number of subjects: 2398

Group type: COMPARATOR
Intervention: G4 rotaviruses
Number of subjects: 2398
Study: 7599448

Group type: EXPERIMENTAL
Intervention: Fluoride treatment (75 mg NaF/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 43
Study: 2223336

Group type: EXPERIMENTAL
Intervention: High frequency jet ventilation (HFJV) at a driving pressure of 1 bar
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High frequency jet ventilation (HFJV)
Number of subjects: 0
Study: 360272

Group type: EXPERIMENTAL
Intervention: Lidocaine administered as a bolus intra-arterially prior to contrast media injections
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lidocaine mixed with contrast agent (2 mgm of lidocaine with each ml of contrast agent)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 30
Study: 31985352

Group type: EXPERIMENTAL
Intervention: Mediterranean diet for 4 days before the second run
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (not specified in detail)
Number of subjects: 11
Study: 30824252

Group type: EXPERIMENTAL
Intervention: Tablet-facilitated TF-CBT
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard TF-CBT
Number of subjects: 27
Study: 28382880

Group type: EXPERIMENTAL
Intervention: Head elevation (HE)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: External laryngeal manipulation (ELM)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Forward laryngoscope traction (FT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no adjunctive maneuvers)
Number of subjects: 22
Study: 25223583

Group type: EXPERIMENTAL
Intervention: CPX-351 (cytarabine: daunorubicin) liposome injection
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control salvage treatment (investigators' choice of first salvage chemotherapy)
Number of subjects: 125
Study: 25299476

Group type: EXPERIMENTAL
Intervention: Spine functional restoration program (5 weeks)
Number of subjects: 134
Study: 21112101

Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 525

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 525
Study: 19304046

Group type: EXPERIMENTAL
Intervention: Nonroutine (NR group) postoperative instructions, including education on the possibility of mandibular fracture and emphasis on a soft diet for 4 weeks.
Number of subjects: 560

Group type: COMPARATOR
Intervention: Routine (R group) postoperative instructions, with no education or emphasis on diet.
Number of subjects: 560
Study: 17329347

Group type: EXPERIMENTAL
Intervention: Surgical Stress Index (SSI) computed from normalized heart beat interval (HBI(norm)) and plethysmographic pulse wave amplitude (PPGA(norm)).
Number of subjects: 60
Study: 15370939

Group type: EXPERIMENTAL
Intervention: Preparation/Action stages of change
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Contemplation Ladder ratings between 8 and 10
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Logistic regression models
Number of subjects: 499
Study: 11349750

Group type: EXPERIMENTAL
Intervention: Mail service pharmacies
Number of subjects: 2437

Group type: EXPERIMENTAL
Intervention: Traditional chain store pharmacies
Number of subjects: 2437

Group type: EXPERIMENTAL
Intervention: Hospital pharmacies
Number of subjects: 2437

Group type: COMPARATOR
Intervention: Independent community pharmacies
Number of subjects: 2437

Group type: COMPARATOR
Intervention: Home health care
Number of subjects: 2437

Group type: COMPARATOR
Intervention: Grocery chain store pharmacies
Number of subjects: 2437

Group type: COMPARATOR
Intervention: Mass merchandise chain store pharmacies
Number of subjects: 2437

Group type: EXPERIMENTAL
Intervention: Overall relationship between prescription orders filled/hour and risk of dispensing errors
Number of subjects: 2437

Group type: EXPERIMENTAL
Intervention: Job satisfaction variables
Number of subjects: 2437
Study: 9879390

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 7517531

Group type: EXPERIMENTAL
Intervention: VDD pacing at AV interval of 100 msec
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: VDD pacing at AV interval of 60 msec
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (sinus rhythm)
Number of subjects: 12
Study: 2566778

Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg twice daily)
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 1072
Study: 31165647

Group type: EXPERIMENTAL
Intervention: Yoga for Cancer Survivors (YOCAS)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Standard survivorship care
Number of subjects: 410
Study: 27751801

Group type: EXPERIMENTAL
Intervention: Protein-enriched readymade meals and protein-enriched bread (5 meals and plentiful bread for 2 weeks)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Protein-enriched readymade meals and protein-enriched bread
Number of subjects: 42

Group type: COMPARATOR
Intervention: Regular equivalents (control group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Protein-enriched products
Number of subjects: 42
Study: 25537443

Group type: EXPERIMENTAL
Intervention: Genium knee
Number of subjects: 30

Group type: COMPARATOR
Intervention: C-Leg knee
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-amputee controls
Number of subjects: 30
Study: 23559219

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotic exposure
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control (no antipsychotic exposure)
Number of subjects: 152
Study: 20622680

Group type: EXPERIMENTAL
Intervention: Intermittent Sequential Compression Device (SCD)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 19531453

Group type: EXPERIMENTAL
Intervention: Bioimmunochemotherapy (BCT) with cisplatin 20 mg/m² i.v. days 1,4; dacarbazine 800 mg/m² i.v. day 1; vinblastine 1.5 mg/m² i.v. days 1,4; IL-2 9 MIU/m² s.c. days 5,8; IFN-alpha-2b 5 MIU/m² s.c. days 5,8,11,13,15; supported by G-CSF and antibiotics
Number of subjects: 11
Study: 18552034

Group type: EXPERIMENTAL
Intervention: Stammberger Sinus Dressing (SSD)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dissolvable Sinu‐Knit (DSK)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine Nasal Packing in Latex Gloves Finger (RNP)
Number of subjects: 45
Study: 14695864

Group type: EXPERIMENTAL
Intervention: Specific balance strategy training programme delivered in a workstation format
Number of subjects: 73

Group type: COMPARATOR
Intervention: Community based exercise class programme (Control)
Number of subjects: 73
Study: 11450888

Group type: EXPERIMENTAL
Intervention: Gemifloxacin
Number of subjects: 617

Group type: COMPARATOR
Intervention: Trovafloxacin
Number of subjects: 617
Study: 9783758

Group type: EXPERIMENTAL
Intervention: Meloxicam (7.5 mg once daily for 28 days)
Number of subjects: 8656

Group type: COMPARATOR
Intervention: Piroxicam (20 mg once daily for 28 days)
Number of subjects: 8656
Study: 8148289

Group type: EXPERIMENTAL
Intervention: Supraclavicular lateral paravascular approach (SCLP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transarterial axillary approach
Number of subjects: 40
Study: 3169753

Group type: EXPERIMENTAL
Intervention: Educational leaflet about gonorrhoea
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no leaflet)
Number of subjects: 0
Study: 30758214

Group type: EXPERIMENTAL
Intervention: Knee Joint Distraction (KJD)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Total Knee Arthroplasty (TKA)
Number of subjects: 114

Group type: COMPARATOR
Intervention: High Tibial Osteotomy (HTO)
Number of subjects: 114
Study: 31482613

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 6632
Study: 28042979

Group type: EXPERIMENTAL
Intervention: L-PRF and BMP-2
Number of subjects: 55

Group type: COMPARATOR
Intervention: L-PRF alone
Number of subjects: 55
Study: 25076119

Group type: EXPERIMENTAL
Intervention: Prehospital TXA infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23878368

Group type: EXPERIMENTAL
Intervention: 250 mg trans-resveratrol
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 20808146

Group type: EXPERIMENTAL
Intervention: Escitalopram (SSRI)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 17242667

Group type: EXPERIMENTAL
Intervention: Comorbidity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metabolic disorders and inflammatory diseases
Number of subjects: 0
Study: 16375658

Group type: EXPERIMENTAL
Intervention: 1,000 mg/day of divalproex sodium
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1,500 mg/day of divalproex sodium
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11973443

Group type: EXPERIMENTAL
Intervention: Transdermal E2/LNG (E2 0.045 mg/day with 0.030 and 0.040 mg/day LNG)
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Transdermal E2/LNG (E2 0.045 mg/day with 0.015, 0.030, and 0.040 mg/day LNG)
Number of subjects: 1138

Group type: COMPARATOR
Intervention: Transdermal E2 0.045 mg/day
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Transdermal E2/LNG and E2
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Transdermal E2/LNG
Number of subjects: 1138
Study: 9472187

Group type: EXPERIMENTAL
Intervention: AED
Number of subjects: 243

Group type: COMPARATOR
Intervention: No AED
Number of subjects: 243
Study: 17252658

Group type: EXPERIMENTAL
Intervention: High-fluoride dentifrice (1450 ppm fluoride)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Low-fluoride dentifrice (250 ppm fluoride)
Number of subjects: 319
Study: 2478428

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with cisplatin, vinblastine, and bleomycin (PVB)
Number of subjects: 368

Group type: COMPARATOR
Intervention: No adjuvant treatment (refused adjuvant therapy)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Adjuvant radiotherapy
Number of subjects: 368

Group type: COMPARATOR
Intervention: Low-risk group (no specific treatment mentioned)
Number of subjects: 368

Group type: COMPARATOR
Intervention: High-risk group (no specific treatment mentioned)
Number of subjects: 368
Study: 824007

Group type: EXPERIMENTAL
Intervention: Combined gamma rays and fast neutrons (mean energy 6 MeV)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Low LET radiation alone (60Co gamma rays)
Number of subjects: 257
Study: 30229847

Group type: EXPERIMENTAL
Intervention: Hydromorphone intravenous analgesia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Morphine intravenous analgesia
Number of subjects: 80
Study: 26892991

Group type: EXPERIMENTAL
Intervention: Human papillomavirus-16/18 vaccination
Number of subjects: 2022
Study: 25486677

Group type: EXPERIMENTAL
Intervention: Personal experiences
Number of subjects: 28

Group type: COMPARATOR
Intervention: Fact-oriented contributions
Number of subjects: 28
Study: 23378397

Group type: EXPERIMENTAL
Intervention: Tobacco smokers
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tobacco abstainers
Number of subjects: 80
Study: 20063137

Group type: EXPERIMENTAL
Intervention: Somatic paravertebral block (SPVB)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no block)
Number of subjects: 36
Study: 18923570

Group type: EXPERIMENTAL
Intervention: C-DEF (exercise with energy balance but carbohydrate deficit)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: C-BAL (exercise with energy and carbohydrate balance)
Number of subjects: 10

Group type: COMPARATOR
Intervention: BASE (no-exercise)
Number of subjects: 10
Study: 16086617

Group type: EXPERIMENTAL
Intervention: Risperidone (1-6 mg/day)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 12756402

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 89
Study: 11099601

Group type: EXPERIMENTAL
Intervention: Methacholine inhalation challenge (group N-A)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Methacholine inhalation challenge (group N-N)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Methacholine inhalation challenge (group A-A)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Comparison of Dmin-PO(2) between groups
Number of subjects: 205
Study: 8628002

Group type: EXPERIMENTAL
Intervention: Lower quadrant carcinoma
Number of subjects: 914

Group type: COMPARATOR
Intervention: Other breast regions carcinoma
Number of subjects: 914
Study: 1446287

Group type: EXPERIMENTAL
Intervention: Thin pedicle skin flap
Number of subjects: 54
Study: 3937508

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0
Study: 30569788

Group type: EXPERIMENTAL
Intervention: Ball-drills training (BDT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Repeated-sprint-ability training (RSAT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: General basketball training (Control)
Number of subjects: 30
Study: 29589562

Group type: EXPERIMENTAL
Intervention: Annotated classification corpus of Chinese health questions (Qcorp)
Number of subjects: 5000
Study: 27221806

Group type: EXPERIMENTAL
Intervention: Dapagliflozin added to metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sulfonylurea (SU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dipeptidyl-peptidase-4 inhibitor (DPP-4i)
Number of subjects: 0
Study: 24299915

Group type: EXPERIMENTAL
Intervention: Resistant hypertension (res‐HTN)
Number of subjects: 17190
Study: 23040575

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon angioplasty
Number of subjects: 2095

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon angioplasty for BMS restenosis
Number of subjects: 2095

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon angioplasty for DES restenosis
Number of subjects: 2095

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon angioplasty for paclitaxel-eluting stent restenosis
Number of subjects: 2095

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon angioplasty for non-paclitaxel-eluting stent restenosis
Number of subjects: 2095

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon angioplasty for de novo lesions
Number of subjects: 2095

Group type: EXPERIMENTAL
Intervention: Definite vessel thrombosis
Number of subjects: 2095
Study: 20812339

Group type: EXPERIMENTAL
Intervention: Prednisolone (20 mg/day for 14 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control subjects (no treatment)
Number of subjects: 20
Study: 17599570

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's (LR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Gelatin polysuccinate 4% (GF)
Number of subjects: 80
Study: 16132799

Group type: EXPERIMENTAL
Intervention: High education level
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Sunburn episodes before age 15
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Light eye colour
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Solar lentigines
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Total number of nevi >30
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Propensity to sunburn
Number of subjects: 542
Study: 12407652

Group type: EXPERIMENTAL
Intervention: 7.5% icodextrin
Number of subjects: 175

Group type: COMPARATOR
Intervention: 2.5% dextrose
Number of subjects: 175
Study: 10617012

Group type: EXPERIMENTAL
Intervention: EACA (5 g bolus, 2 g/h infusion, 2.5 g in priming)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: TA (1 g bolus, 400 mg/h infusion, 500 mg in priming)
Number of subjects: 210

Group type: COMPARATOR
Intervention: AP (280 mg bolus, 70 mg/h infusion, 280 mg in priming)
Number of subjects: 210
Study: 7581055

Group type: EXPERIMENTAL
Intervention: Salbutamol inhalation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 28
Study: 1985413

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (20 mg/kg im soon after birth, and at 24 and 48 hours)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (single dose of 20 mg/kg)
Number of subjects: 230
Study: 6189581

Group type: EXPERIMENTAL
Intervention: Radiation therapy for cerebral metastases
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Radiation therapy for headaches
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Radiation therapy for convulsions
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Radiation therapy for motor loss
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Radiation therapy for bone metastases in prostatic carcinoma
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Radiation therapy for bone metastases in renal primaries
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Radiation therapy for pain relief at eight weeks
Number of subjects: 225

Group type: COMPARATOR
Intervention: Radiation therapy for total group of patients
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Median survival for solitary bone metastases from prostatic primary
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Median survival for multiple metastatic sites
Number of subjects: 225
Study: 31841515

Group type: EXPERIMENTAL
Intervention: Hybridization of C. nouraguensis females and C. becei males
Number of subjects: 0
Study: 30571423

Group type: EXPERIMENTAL
Intervention: Complete reperfusion after endovascular thrombectomy
Number of subjects: 381
Study: 26768131

Group type: EXPERIMENTAL
Intervention: Facilitative tutoring (f)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-facilitative tutoring (nf)
Number of subjects: 0
Study: 24145045

Group type: EXPERIMENTAL
Intervention: Blocked practice
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Serial practice
Number of subjects: 36

Group type: COMPARATOR
Intervention: No practice (Control)
Number of subjects: 36
Study: 21339433

Group type: EXPERIMENTAL
Intervention: Casopitant plus ondansetron (oral casopitant 50 mg + intravenous ondansetron 4 mg)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Ondansetron only (intravenous ondansetron 4 mg)
Number of subjects: 484
Study: 19900234

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg twice daily
Number of subjects: 51

Group type: COMPARATOR
Intervention: Amitriptyline 50 mg at night
Number of subjects: 51
Study: 17034288

Group type: EXPERIMENTAL
Intervention: Electroacupuncture to the contralateral ST36 acupuncture point (right side)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Electroacupuncture to the ipsilateral ST36 acupuncture point (left side)
Number of subjects: 40
Study: 15354947

Group type: EXPERIMENTAL
Intervention: Pulse intravenous cyclophosphamide
Number of subjects: 28

Group type: COMPARATOR
Intervention: Daily oral cyclophosphamide
Number of subjects: 28
Study: 10651841

Group type: EXPERIMENTAL
Intervention: rhEPO plus intravenous iron sucrose (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: rhEPO placebo plus intravenous iron sucrose (group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: oral iron alone (group 3)
Number of subjects: 60
Study: 9580102

Group type: EXPERIMENTAL
Intervention: Isoxsuprine (50 mg in 250 ml of DW5%)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Isoxsuprine
Number of subjects: 50
Study: 8160562

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 38

Group type: COMPARATOR
Intervention: Cetirizine 20 mg (10 mg twice a day)
Number of subjects: 38